Argenx
ARGX
#526
Rank
โ‚น4.183 T
Marketcap
โ‚น67,609
Share price
-1.11%
Change (1 day)
35.54%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): โ‚น776.72

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น816.39. In 2024 the company made an earnings per share (EPS) of โ‚น1,281 an increase over its 2023 EPS that were of -โ‚น474.93.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น776.72-39.38%
2024โ‚น1,281-369.77%
2023-โ‚น474.93-60.46%
2022-โ‚น1,20163.33%
2021-โ‚น735.40-40.37%
2020-โ‚น1,233183.47%
2019-โ‚น435.08123.09%
2018-โ‚น195.0354.93%
2017-โ‚น125.8814.07%
2016-โ‚น110.3513.05%
2015-โ‚น97.61-36.34%
2014-โ‚น153.33209.04%
2013-โ‚น49.62-33.99%
2012-โ‚น75.17185.59%
2011-โ‚น26.32